ArticleLancet regional health. Americas2024

Long-term overall survival of patients who undergo breast-conserving therapy or mastectomy for early operable HER2-Positive breast cancer after preoperative systemic therapy: an observational cohort study.

Xuexin He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.